메뉴 건너뛰기




Volumn 5, Issue 10, 2009, Pages 557-559

Glomerular disease: The Oxford classificationpredicting progression of IgAN

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CLASSIFICATION; DISEASE COURSE; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MEDICAL DECISION MAKING; PRIORITY JOURNAL; SHORT SURVEY;

EID: 70349618909     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2009.150     Document Type: Short Survey
Times cited : (9)

References (6)
  • 1
    • 68949206247 scopus 로고    scopus 로고
    • The Oxford classification of igA nephropathy: Pathology definitions, correlations, and reproducibility
    • Roberts, i. s. et al. The Oxford classification of igA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 76, 546-556 (2009).
    • (2009) Kidney Int , vol.76 , pp. 546-556
    • Roberts, S.1
  • 2
    • 68949218774 scopus 로고    scopus 로고
    • The Oxford classification of igA nephropathy: Rationale, clinicopathological correlations, and classification
    • Cattran, D. C. et al. The Oxford classification of igA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int. 76, 534-545 (2009).
    • (2009) Kidney Int , vol.76 , pp. 534-545
    • Cattran, D.C.1
  • 3
    • 1642480050 scopus 로고    scopus 로고
    • The classification of glomerulonephritis in systemic lupus erythematosus revisited
    • weening, J. J. et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 65, 521-530 (2004).
    • (2004) Kidney Int , vol.65 , pp. 521-530
    • Weening, J.J.1
  • 4
    • 52049114193 scopus 로고    scopus 로고
    • Supportive versus immunosuppressive therapy of progressive igA nephropathy (sTOP) igAn trial: Rationale and study protocol
    • eitner, F., Ackermann, D., Hilgers, R. D. & Floege, J. supportive versus immunosuppressive therapy of progressive igA nephropathy (sTOP) igAn trial: rationale and study protocol. J. Nephrol. 21, 284-289 (2008).
    • (2008) J. Nephrol. , vol.21 , pp. 284-289
    • Eitner, F.1    Ackermann, D.2    Hilgers, R.D.3    Floege, J.4
  • 5
    • 67651006853 scopus 로고    scopus 로고
    • Aberrantly glycosylated igA1 in igA nephropathy patients is recognized by igG antibodies with restricted heterogeneity
    • suzuki, H. et al. Aberrantly glycosylated igA1 in igA nephropathy patients is recognized by igG antibodies with restricted heterogeneity. J. Clin. Invest. 119, 1668-1677 (2009).
    • (2009) J. Clin. Invest. , vol.119 , pp. 1668-1677
    • Suzuki, H.1
  • 6
    • 0033762699 scopus 로고    scopus 로고
    • IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23
    • Gharavi, A. G. et al. igA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet. 26, 354-357 (2000).
    • (2000) Nat. Genet. , vol.26 , pp. 354-357
    • Gharavi, A.G.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.